文献速递肝病消化道肿瘤与早癌

肝癌起源细胞、分子分型及其对患者预后的影响

Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.
PubMed 文献 · Gastroenterology · 2016-12-30

原发性肝癌是全球癌症死亡第二大原因。本文综述肝癌起源细胞假说,基于分子特征对肝细胞癌和肝内胆管癌进行分类,并阐述各分子亚型对患者预后的影响及潜在治疗靶点。

要点

  • 成人肝细胞、肝祖细胞均可作为肝癌起源细胞,通过直接转化、去分化或转分化等途径形成肝细胞癌或肝内胆管癌。
  • 肝细胞癌分子分型包括增殖-祖细胞型、增殖-转化生长因子β型、Wnt-β1连环蛋白型;肝内胆管癌分为增殖型和炎症型。
  • 增殖亚型总体与更具侵袭性的表型和不良预后相关;FGFR2融合、IDH基因突变(约60%肝内胆管癌)及11q13、6p21扩增(约15%肝细胞癌)为潜在治疗靶点。

核心结论

  • 增殖亚型总体与更具侵袭性的表型和患者不良预后相关,但更特异的分子特征进一步细化了预后判断能力。
  • 遗传学改变分析发现了可能用于治疗的靶点,如FGFR2基因融合、异柠檬酸脱氢酶基因突变(约60%的肝内胆管癌)以及11q13和6p21扩增(约15%的肝细胞癌)。
  • 在将这些改变用作临床决策生物标志物之前,尚需进一步研究。

研究设计与样本

  • 综述,总结肝癌起源细胞假说,并基于分子特征对肝癌进行分类,阐述其对患者预后的影响。

主要发现

  • 成人肝细胞被提出可通过直接转化为肝细胞癌、去分化为肝细胞前体细胞(进而成为表达祖细胞标志物的肝细胞癌)或转分化为胆管样细胞(进而形成肝内胆管癌)。
  • 肝祖细胞也可产生带有祖细胞标志物的肝细胞癌和肝内胆管癌。
  • 肝细胞癌基于分子特征分为增殖-祖细胞型、增殖-转化生长因子β型和Wnt-β1连环蛋白型等类别;肝内胆管癌分为增殖型和炎症型。
  • 增殖亚型总体与更具侵袭性的表型和患者不良预后相关,但更特异的分子特征进一步细化了预后判断能力。
  • 异柠檬酸脱氢酶基因突变见于约60%的肝内胆管癌;11q13和6p21扩增见于约15%的肝细胞癌。

关键数值与推荐

  • 原发性肝癌包括肝细胞癌、肝内胆管癌及其他罕见肿瘤,尤其是纤维板层型癌和肝母细胞瘤。
  • 肝细胞癌与肝内胆管癌的分子和临床特征不同,但两者风险因素和致癌通路存在重叠。
  • 肝细胞癌分子分型包括增殖-祖细胞型、增殖-转化生长因子β型、Wnt-β1连环蛋白型。
  • 肝内胆管癌分子分型包括增殖型和炎症型。
  • 异柠檬酸脱氢酶基因突变约见于60%的肝内胆管癌;11q13和6p21扩增约见于15%的肝细胞癌。

临床怎么用

  • 原文未据此给出推荐。
  • 原文结论指出,在遗传学改变可用作临床决策生物标志物之前,尚需进一步研究。

局限性

  • 在遗传学改变可用作临床决策生物标志物之前,尚需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Primary liver cancer is the second leading cause of cancer-related death worldwide and therefore a major public health challenge. We review hypotheses of the cell of origin of liver tumorigenesis and clarify the classes of liver cancer based on molecular features and how they affect patient prognosis. Primary liver cancer comprises hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (iCCA), and other rare tumors, notably fibrolamellar carcinoma and hepatoblastoma. The molecular and clinical features of HCC versus iCCA are distinct, but these conditions have overlapping risk factors and pathways of oncogenesis. A better understanding of the cell types originating liver cancer can aid in exploring molecular mechanisms of carcinogenesis and therapeutic options. Molecular studies have identified adult hepatocytes as the cell of origin. These cells have been proposed to transform directly into HCC cells (via a sequence of genetic alterations), to dedifferentiate into hepatocyte precursor cells (which then become HCC cells that express progenitor cell markers), or to transdifferentiate into biliary-like cells (which give rise to iCCA). Alternatively, progenitor cells also give rise to HCCs and iCCAs with markers of progenitor cells. Advances in genome profiling and next-generation sequencing have led to the classification of HCCs based on molecular features and assigned them to categories such as proliferation-progenitor, proliferation-transforming growth factor β, and Wnt-catenin β1. iCCAs have been assigned to categories of proliferation and inflammation. Overall, proliferation subclasses are associated with a more aggressive phenotype and poor outcome of patients, although more specific signatures have refined our prognostic abilities. Analyses of genetic alterations have identified those that might be targeted therapeutically, such as fusions in the FGFR2 gene and mutations in genes encoding isocitrate dehydrogenases (in approximately 60% of iCCAs) or amplifications at 11q13 and 6p21 (in approximately 15% of HCCs). Further studies of these alterations are needed before they can be used as biomarkers in clinical decision making.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Sia D, Villanueva A, Friedman SL, et al. Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis. Gastroenterology. 2016. PMID: 28043904. doi:10.1053/j.gastro.2016.11.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。